Exagen Gross Profit Growth & History (XGN)

Exagen's gross profit was $38.8M for fiscal 2025.

View full Exagen company overview

Exagen annual gross profit history

Exagen annual gross profit

Fiscal yearPeriod endedGross profitChangeGrowth
20252025-12-31$38.8M$5.7M+17.18%
20242024-12-31$33.1M$3.7M+12.41%
20232023-12-31$29.5M$8.1M+37.97%
20222022-12-31$21.3M−$6.4M−22.96%
20212021-12-31$27.7M$2.3M+9.03%
20202020-12-31$25.4M$3.8M+17.78%
20192019-12-31$21.6M$4.5M+26.48%
20182018-12-31$17.1M

Exagen gross profit trends

Over the last five fiscal years, Exagen's gross profit increased from $25.4M to $38.8M, a change of $13.4M. The latest reported quarter, Q2 2026, shows $12.2M.

About the metric

What gross profit means

Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.

Calculation and source

SEC-reported and calculated gross profit

TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Exagen source filings ↗

Community posts

It’s quiet here.

No posts about XGN yet. Start the conversation.

Write the first post